-
Mashup Score: 3
Telestroke assessments are widely used to rapidly assess adults presenting to remote facilities with suspected stroke, though they have not been studied in children. SPOT, the Study of performing the PedNIHSS over Televideo, tested the feasibility of assessing the pediatric National Institutes of Health stroke scale (PedNIHSS) by televideo in children.
Source: www.pedneur.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 1Review of sleep medicine - 5 month(s) ago
The preface states that the book is intended as a study guide for individuals taking board examinations in sleep medicine. There are 18 co-authors, many of whom are reputed for major contributions to the field.
Source: www.pedneur.comCategories: General Medicine News, Hem/OncsTweet-
RT @pedneurojournal: https://t.co/A8dVS2UUZl https://t.co/nZvAZihgoG @GraceGombolayMD @LakhotiaNeuro
-
-
Mashup Score: 7
Parents of neonates with seizures report persistent symptoms of depression, anxiety, and post-traumatic stress. We aimed to characterize the parent experience of caring for children impacted by neonatal seizures, including longitudinal assessment across childhood.
Source: www.pedneur.comCategories: General Medicine News, Hem/OncsTweet-
RT @pedneurojournal: Read this study from @pedneurojournal here https://t.co/mXjNRWkQYX 📸 Slide from #CNSAM Year in Review https://t.co…
-
-
Mashup Score: 83
Anti-myelin oligodendrocyte glycoprotein (MOG) antibody disease (MOGAD) is a type of acquired demyelinating disease that is distinct from multiple sclerosis (MS) and aquaporin-4 antibody neuromyelitis optica spectrum disorder (AQP4-NMOSD). Leptomeningeal enhancement (LME) has been reported in children and adults with MOGAD, and in adults with MS and AQP4-NMOSD, but less is known about LME in pediatric-onset MS (POMS) and pediatric AQP4-NMOSD. Here we compare the rates of LME in children with MOGAD, POMS, and AQP4-NMOSD.
Source: www.pedneur.comCategories: General Medicine News, Expert PicksTweet-
Honored that our MOGAD study in @pedneurojournal was featured in the #CNSAM year in review! 30% of MOGAD have leptomeningeal enhancement as compared to 0% of MS and AQP4 NMOSD. @ChildNeuroSoc @AdGoldmanYassen @The_ASPNR @NeurologyATL @PedNroEmoryCHOA https://t.co/t9ARXfh12L
-
-
Mashup Score: 2
To investigate the long-term outcome of pediatric mild traumatic brain injury (mTBI) in terms of neurocognitive, behavioral, and school functioning and to identify clinical risk factors for adverse outcomes.
Source: www.pedneur.comCategories: General Medicine News, Hem/OncsTweet-
RT @pedneurojournal: Long term neurodevelopmental outcomes of mild TBI in children? https://t.co/0D5yz2KqLS - Prospective - n= 89 - 3.6…
-
-
Mashup Score: 1Efficacy and Side Effects of Topiramate in Treatment of Children With Pseudotumor Cerebri Syndrome - 7 month(s) ago
Topiramate is often considered as a second-line medication for the treatment of pseudotumor cerebri syndrome (PTCS), but limited studies exist that evaluate its efficacy in children.
Source: www.pedneur.comCategories: General Medicine News, Hem/OncsTweet-
RT @pedneurojournal: This study looks into the role of topiramate (TPM) in management of IIH in children https://t.co/LJ2WsTrKZu 💊 2nd…
-
-
Mashup Score: 12Pediatric palliative epilepsy surgery: a report from the Pediatric Epilepsy Research Consortium (PERC) Surgery Database - 11 month(s) ago
Epilepsy is common, occurring in 0.5-1.5% of the pediatric US population, with drug-resistant epilepsy (DRE) occurring in nearly one-third of persons with epilepsy under 18 years of age.1,2,3,50 The International League Against Epilepsy (ILAE) defines DRE as “failure of adequate trials of two tolerated, appropriately chosen and used, antiepileptic drug schedules to achieve sustained seizure freedom”.4 After two anti-seizure medications (ASMs) have failed, the likelihood that an additional ASM will lead to seizure freedom is around 4-5%.
Source: www.pedneur.comCategories: General Medicine News, NeurologyTweet-
The latest article from @PERCepilepsy Surgery Database is online now! We explore use of palliative epilepsy surgery (ie procedures not expected to result in seizure freedom - 🤔 needs a better name than palliative) in the US https://t.co/52SgyvymBQ
-
-
Mashup Score: 11Pediatric palliative epilepsy surgery: a report from the Pediatric Epilepsy Research Consortium (PERC) Surgery Database - 12 month(s) ago
Epilepsy is common, occurring in 0.5-1.5% of the pediatric US population, with drug-resistant epilepsy (DRE) occurring in nearly one-third of persons with epilepsy under 18 years of age.1,2,3,50 The International League Against Epilepsy (ILAE) defines DRE as “failure of adequate trials of two tolerated, appropriately chosen and used, antiepileptic drug schedules to achieve sustained seizure freedom”.4 After two anti-seizure medications (ASMs) have failed, the likelihood that an additional ASM will lead to seizure freedom is around 4-5%.
Source: www.pedneur.comCategories: General Medicine News, NeurologyTweet-
The latest article from @PERCepilepsy Surgery Database is online now! We explore use of palliative epilepsy surgery (ie procedures not expected to result in seizure freedom - 🤔 needs a better name than palliative) in the US https://t.co/52SgyvymBQ
-
-
Mashup Score: 15Evidence of Diplopia in Children's Headache Drawings Helps to Differentiate Pseudotumor Cerebri From Migraine - 12 month(s) ago
This study aimed to determine whether children’s headache drawings can distinguish between pseudotumor cerebri and migraine.
Source: www.pedneur.comCategories: General Medicine News, NeurologyTweet-
Young children may have a hard time articulating details of their headache. This is where a little creativity can help ⬇️ Asking children to draw their headaches can provide important diagnostic clues (Image from https://t.co/nNQZbgARkm) https://t.co/EO5qt8cM7n
-
-
Mashup Score: 4Practical considerations for delandistrogene moxeparvovec gene therapy in patients with Duchenne muscular dystrophy - 1 year(s) ago
Delandistrogene moxeparvovec is a gene transfer therapy approved in the United States, United Arab Emirates, and Qatar for the treatment of ambulatory patients aged 4 through 5 years with a confirmed Duchenne muscular dystrophy (DMD)-causing mutation in the DMD gene. It was developed to address the underlying cause of DMD through targeted skeletal, respiratory, and cardiac muscle expression of delandistrogene moxeparvovec micro-dystrophin, an engineered, functional dystrophin protein. Drawing on clinical trial experience from Study 101 (NCT03375164), Study 102 (NCT03769116), and ENDEAVOR (Study 103; NCT04626674), we outline practical considerations for delandistrogene moxeparvovec treatment.
Source: www.pedneur.comCategories: General Medicine News, Hem/OncsTweet-
RT @LakhotiaNeuro: Nice review paper of practical considerations for gene replacement therapy for #DMD - https://t.co/Ma9gzFODH4 #OpenA…
-
Is there a SPOT for remote pediatric stroke evaluation in the world of telestroke networks? A pilot Feasibility Study of Performing the PedNIHSS Over Televideo - Pediatric Neurology https://t.co/WroT5iRWt0